內媒指碧桂園(02007.HK)將啟動境外債務重組
內地《澎湃新聞》報道,碧桂園(02007.HK)境內債務處理告一段落,接著將處理境外債務,已委托中金公司作為財務顧問,協助處理境外債務重組事宜。
報道指,據不完全統計,目前碧桂園2023年和2024年到期的境外債券共7隻,餘額包括30億港元、29.74億泰銖和15.5億美元。
另外有投資者表示,未收到一項碧桂園債券「N20240127」的票息,該項債券2018年9月28日上市,將於2024年1月27日到期,每年3月27日、9月27日付息,債券利率8%,當前餘額9.65億美元,今次應支付利息約3,860萬美元,有30天的支付寬限期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.